The Food and Drugs Authority (FDA) in Ghana has reaffirmed its commitment to developing and implementing a code of conduct for public officials. This initiative aims to prevent interference from the tobacco industry in policy-making processes. Dr. Martin Kuai, Acting Director of the Tobacco and Substances of Abuse Directorate at the FDA, made this statement at a stakeholders' meeting in Accra. The meeting was organized by Vision for Accelerated Sustainable Development, Ghana (VAST Ghana), a public health advocate.
Dr. Kuai emphasized that tobacco use is a leading preventable cause of diseases and death globally. Ghana has made significant strides in addressing this issue, including the enactment of the Public Health Act 2012 (Act 851) and the Tobacco Control Regulations LI 2247. These laws demonstrate the country's commitment to reducing the burden of tobacco-related diseases. The FDA's efforts to develop a code of conduct are part of a broader strategy to protect public health policies from commercial vested interests.
The development of the code of conduct has been a participatory process, involving various stakeholders, including civil society organizations (CSOs), academia, professional bodies, and development partners. The FDA has worked closely with the Ministry of Health, the Public Services Commission, and the Office of the Head of Civil Service to ensure a comprehensive approach. Dr. Kuai highlighted the importance of insulating public health policy-making from commercial interests, citing Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC).
The tobacco industry's interference has been shown to delay, weaken, or undermine public health legislation worldwide. Dr. Kuai stressed that the implementation of the code of conduct would require collaboration between government agencies, CSOs, and other stakeholders. The framework envisages CSOs playing a crucial role in monitoring tobacco industry activities, providing transparency, and contributing to feedback.
Mr. Christian Nii Ayi Welbeck, a Revenue Officer at the Ghana Revenue Authority (GRA), expressed his organization's support for the code of conduct. He noted that tobacco-related diseases, such as hypertension, heart diseases, and cancers, cost the country GHc668 million annually, equivalent to 0.2% of Ghana's GDP. The GRA supports the use of a code of conduct as a means of limiting tobacco consumption and promoting prevention.
Mr. Labram Musah, Executive Director of VAST Ghana, welcomed the stakeholders' meeting and emphasized the need for a code of conduct to guide public officials' interactions with the tobacco industry. He noted that the industry often uses front groups and entities to influence policies and regulatory processes, posing a significant challenge to effective tobacco control. A well-designed code of conduct can provide practical guidance on interacting with the tobacco industry.
The development of the code of conduct is a critical step towards protecting public health policies from commercial vested interests. The FDA's commitment to this initiative demonstrates its dedication to reducing the burden of tobacco-related diseases in Ghana. Key stakeholders, including CSOs, government agencies, and development partners, will play a crucial role in implementing and monitoring the code of conduct.
Key points
- The FDA is committed to developing a code of conduct for public officials to prevent tobacco industry interference in policy-making processes.
- The code of conduct aims to provide practical guidance on interacting with the tobacco industry and managing conflicts of interest.
- The implementation of the code of conduct will require collaboration between government agencies, CSOs, and other stakeholders.
